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ABSTRACT
Reliable methods for conditional gene silencing in
bacteria have been elusive. To improve silencing
by expressed antisense RNAs (asRNAs), we syste-
matically altered several design parameters and
targeted multiple reporter and essential genes
in Escherichia coli. A paired termini (PT) design,
where flanking inverted repeats create paired
dsRNA termini, proved effective. PTasRNAs tar-
geted against the ackA gene within the acetate
kinase-phosphotransacetylase operon (ackA-pta)
triggered target mRNA decay and a 78% reduction
in AckA activity with high genetic penetrance.
PTasRNAs are abundant and stable and function
through an RNase III independent mechanism that
requires a large stoichiometric excess of asRNA.
Conditional ackA silencing reduced carbon flux
to acetate and increased heterologous gene expres-
sion. The PT design also improved silencing of
the essential fabI gene. Full anti-fabI PTasRNA
induction prevented growth and partial induction
sensitized cells to a FabI inhibitor. PTasRNAs have
potential for functional genomics, antimicrobial
discovery and metabolic flux control.
INTRODUCTION
Advanced genetics and metabolic engineering require reliable
conditional gene control. Unfortunately, gene disruption
techniques remain difﬁcult, applicable to a restricted set of
species and strains and are particularly problematic in cases
where the target gene is growth critical. In many eukaryotic
systems, antisense and RNAi-mediated gene silencing is
popular, whereas in bacteria RNAi mechanisms are absent
and antisense technology is less developed and applied.
Expressed antisense RNAs (asRNAs) appear to be suitable
for conditional gene silencing in diverse bacteria (1,2) and for
large scale applications. Indeed, asRNA can repress trans-
lation in diverse bacteria (3–8), and library screens have
revealed effective antisense transcripts and putative new
essential genes (9,10) and inhibitors (11). The expressed
asRNA method may be more efﬁcient in Gram-positive
bacteria such as Staphylococcus aureus (5,9–11) and
Clostridium acetobutylicum (7,12) relative to Gram-negative
bacteria, such as Escherichia coli, but reports of mixed results
(13) suggest that design improvements are needed. Also,
bacteria have endogenous asRNA regulators (14) and cell
permeable modiﬁed antisense agents are efﬁcient inhibitors
(15,16). Therefore, achieving improved antisense silencing
in E.coli appears to be largely a technical challenge.
Here we found that a simple paired-termini (PT) design
stabilizes asRNA cassettes and enhances conditional gene
silencing in E.coli. Two well-characterized and tractable
genes were targeted using a range of design variants.
The results show that PTasRNAs are stabilized, accumulate
following induction and provide reliable gene inhibition
that is sufﬁcient to alter growth phenotypes. The approach
is compatible with comprehensive forward and reverse
RNA-level genetics of both essential and non-essential
bacterial genes and there are potential applications in
pharmaceutical discovery and metabolic engineering.
MATERIALS AND METHODS
Culture conditions and general techniques
Luria–Bertani (LB) media are comprised of 1% Bacto
tryptone, 0.5% Bacto yeast extract and 0.5% NaCl. M9
media comprises 17 mg/ml Na2HPO4 12H2O, 3 mg/ml
KH2PO4, 0.5 mg/ml NaCl, 1 mg/ml NH4Cl, 2 mM MgSO4,
0.1 mM CaCl2, 50 mg/ml leucine [TOP10 (Invitrogen
Corp.) is a leucine auxotrophic strain]. E.coli TOP10 strain
was used as a host cell throughout the experiments and
grown in LB media at 37 C if not otherwise speciﬁed. M9
media with 2% glucose or with 2 mg/ml sodium acetate or
M9Z media (M9 media plus 0.1% NZ-amine) with 2%
glucose was used. Antibiotics were included to maintain
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34 mg/ml; kanamycin, 20 mg/ml; ampicillin, 70 mg/ml for
LB media or 35 mg/ml for M9-based media. For induction,
transformants pre-grown overnight in the absence of the
inducer were diluted 1:400 with the media containing one
of the inducers and grown to logarithmic phase (absorbance
at 550 nm ¼ 0.6–0.8). As an inducer, 0.2% of arabinose
or 1 mM of IPTG in ﬁnal concentration was used if not
otherwise speciﬁed. In the absence of inducer, no inhibition
of target gene expression was observed in all experiments
unless the constitutive promoter was used (data not shown).
Plasmid constructs and further information are described
in Supplementary Materials and Methods, Figure S1 and
Table S1.
Cell extracts in phosphate-buffered saline were prepared
using Silica beads (0.1 mm diameter, www.biospec.com)
and a Beadbeater 3110BX (www.biospec.com). Protein
concentration was estimated by Bradford-assay (Bio-Rad
laboratories Inc.). b-Galactosidase activity was measured as
described Ref. (16). All P-values are two tailed and were
calculated at http://faculty.vassar.edu/lowry/VassarStats.html.
Extracellular acetate concentration was measured with
an enzymatic test kit (Boehringer-Mannheim, Darmstadt,
Germany) according to the manufacturer’s instruction.
AckA assay
Cell extracts (20 ml, typically 1 mg/ml of protein concen-
tration) were mixed with 60 ml of reaction buffer [200 mM
Tris–HCl (pH 8.0), 10 mM ATP, 267 mM potassium
acetate, 10 mM MgCl2, 6% hydroxylamine hydrochloride
(neutralized with KOH before using)] and incubated for
60 min at 37 C (17). The reaction was stopped by the
addition of 60 ml of 10% trichloroacetic acid followed by
the addition of 10 ml of 2.5% FeCl3 (dissolved in 2N HCl).
After the debris was removed by brief centrifugation,
120 ml of the mixture was transferred to the 96-well plate
(FALCON 3072, Becton Dickinson Labware Co.) and
absorbance of red color was measured at 540 nm (A1540)
using VERSAmax spectrophotometer (Molecular Devices
Corporation, CA, USA). As a control, the same reaction
was performed with PBS substituted for cell extract
(A0540). A0540 values were subtracted from A1540 values
(A1540   A0540 ¼ A2540) and activity was calculated as
A2540/mg protein/ml (units).
Pta assay
The reaction mixture (180 ml) was prepared in the 96-well
plate and contained 200 mM Tris–HCl (pH 8.0), 5 mM
MgCl2, 9.8 mM NAD
+, 3.75 mM CoA, 15 mM malic acid,
20 mM acetyl phosphate (lithium potassium salt), 2.3 U/ml
citrate synthase, 3.3 U/ml malate dehydrogenase and cell
extract (typically, 0.05 mg/ml of protein concentration) at
37 C (18). Absorbance of NADH was read at 340 nm each
minute and the slope of the conversion curve was used to
calculate the speciﬁc activity/mg protein/min/ml.
GFP assay
To measure green ﬂuorescent protein (GFP) ﬂuorescence
in liquid media, transformants were cultured in a ﬂask con-
taining 12 ml M9Z glucose media and IPTG was added at
culture density 0.6–0.7. GFP ﬂuorescence was monitored
with a NOVOstar ﬂuorescence/luminescence reader (BMG
Labtechnologies) with 180 ml cell culture placed in a
96-well plate (COSTAR 3632, Corning Inc.), using 390 nm
excitation and 520 nm emission wavelengths. GFP ﬂuores-
cence on solid media was detected on inverted plates using
a Typhoon 9400 (Amersham Biosciences) with 488 excitation
and 520 emission ﬁlters.
RNA analysis by northern blot
Total RNAs were puriﬁed by the hot acid-phenol method
(19). To determine RNA half-lives, cells were treated with
250 mg/ml of rifampicin [stock solution was dissolved with
dimethyl sulfoxide (DMSO), 50 mg/ml] and RNA degrada-
tion was stopped immediately by the addition of an ethanol–
phenol solution (20). Northern blots were carried out using
AlkPhosDirect Labelling and Detection System (Amersham
Biosciences) according to the manufacturers’ instructions.
For detection of ackA asRNAs, ECF substrate (Amersham
Biosciences) was used, whereas for ackA-pta mRNA, the
chemiluminescent CDP-star substrate (Amersham Bio-
sciences) was used. Typically, 25 mg/ml of total RNAs
were loaded for each lane and ribosomal RNA bands were
visualized by ethidium bromide staining followed by
scanning with a Typhoon 9400 (excitation and emission
wavelengths were 532 and 610 nm, respectively). Band
densities were estimated with ImageJ software (http://rsb.
info.nih.gov/ij/). A double-stranded DNA probe for ackA
mRNA (probe A, 1.2 kb) was prepared by PCR using
sSN17, sSN6 and pHN551 (see Supplementary Materials
and Methods for details). Sequences of single-stranded
oligonucleotide probes used for detection of ackA asRNAs
were ATAGGTACTTCCATGTCGAGTAAGTTAGTACTG-
GTTCTGAACTGCGGTAGTTC (probe B) and CCGCTTC-
TGCGTTCTGATTTAATCTGTATCAGGCTGAAAATCT-
TCTCTCATCCG (probe C).
Lengths of asRNAs are predicted from transcription start
site of the Pbad or Ptrc to the end of the stem–loop structre
of the rrnB terminator. Predicted asRNA lengths are: ackA
asRNA without PT, 454 bp; ackA-PT1 asRNA, 479 bp;
ackA-PT2 asRNA, 495 bp; ackA-PT3 asRNA, 514 bp;
ackA-PT4 asRNA, 476 bp; ackA-PT5 asRNA, 276 bp;
ackA-PT6 asRNA, 336 bp; ackA-PT7 asRNA, 499 bp;
ackA-PT7D asRNA, 460 bp.
Zone of inhibition assay on agar plates
Mixtures consisting of 8 ml LB-1.1% agar (autoclaved and
cooled to 40 C), 0.04 mM IPTG and 50 ml of an overnight
culture of cells harboring the fabI-PT7 asRNA plasmid or
the control PT7 plasmid were solidiﬁed in petri dishes and
2.5 ml of inhibitor solution was applied to plate surfaces.
The plates were incubated for 14 h, stained by adding
1.8 ml of acridine orange solution (60 mg/ml) and scanned
with a Typhoon 9400 scanner (excitation and emission wave-
lengths were 488 and 526 nm, respectively). Inhibitors were
dissolved in 10% DMSO. DMSO alone was not inhibitory
and we conducted the same experiments in the absence of
IPTG and conﬁrmed there were no changes in zone sizes
for the control strains (data not shown).
e138 Nucleic Acids Research, 2006, Vol. 34, No. 20 PAGE 2 OF 10RESULTS
asRNA expression and silencing of ackA-lacZ
To assess silencing by expressed RNA, we ﬁrst targeted ackA
within the ackA-pta operon as an example of a metabolic
gene that is experimentally tractable and an interesting candi-
date for conditional control in industrial applications (21).
AckA is central to carbon ﬂux to and from acetate. In aerobic
industrial fermentations, overﬂow metabolism to acetate
reduces growth and inhibits macromolecule biosynthesis
and product yields (22). The ackA-pta operon was targeted
previously using standard asRNA strategies with modest
effects ( 10–20% inhibition) (3). To ease comparison of
asRNA design parameters (Figure 1), we constructed a
reporter plasmid containing ackA-lacZ translational fusion,
where expression is driven by the native ackA promoter
(Figure 2A). An ackA asRNA-expressing plasmid was con-
structed, containing the arabinose-inducible bad promoter
(Pbad), araC and rrnB terminator. The reporter plasmid and
asRNA-expressing plasmid carry different replication origins
and selection markers, allowing stable maintenance of
co-transformants (for details, see Supplementary Figure S1).
To benchmark our analyses to standard asRNA designs, we
expressed a previously described 147 base ackA asRNA com-
plementary to the 50-untranslated region (50-UTR) and start
codon region (3), without ﬂanking sequence modiﬁcation.
This construct inhibited expression only 15%, similar to the
results reported earlier (3) and not signiﬁcantly different
than control levels (P ¼ 0.17). In addition, ﬂanking sequences
that are reported to stabilize RNAs were added to the ackA
asRNA sequence (6), including the 50-UTR sequence of
ompA mRNA (121 bp) (23–25), and the 30 end of DsrA
RNA (67 bp) (23). However, these ﬂanking sequences did
not improve inhibition (data not shown). Therefore, the exist-
ing asRNA designs did not provide sufﬁcient silencing in
these assays.
Improved gene silencing using PTasRNAs
An alternative strategy to stabilize asRNAs is to pair the ter-
mini using ﬂanking inverted repeats to create a hairpin struc-
ture with the antisense sequence within a large loop
(Figure 1). To test this design, we compared the efﬁcacy of
Pbad-driven ackA asRNA cassettes (147 bp, shown as type
L in Figure 2) ﬂanked by PT consisting of 21–57 bp. The
PT contains a high GC content to strengthen pairing and resist
double-stranded RNA speciﬁc RNase degradation (26)
(Figure 1, PT1-3). Addition of PT to asRNA improved silenc-
ing (P < 0.01) and appeared to improve with PT length
(Figure 2B). However, we suspect that plasmid stability is
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Figure 1. Expressed asRNA structures. (A) Thick lines (curved or linear) indicate antisense sequences (or an MCS control sequence). PT consisting of non-
endogenous GC-rich sequences are indicated by thin-black lines, and thin-gray lines are 50 leader sequences. Numbers between dots indicate the lengths of 30
extensions (bp). All constructs end with the stem–loop structre of the rrnB terminator (rrnB T1). Arrows indicate promoters. Wavy lines indicate lac operator
sequences. (B) The predicted structure of PT7-asRNA. Boxes indicate the lac operator.
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ciencies for PT3-containing-plasmids was lower than
observed for other plasmids (data not shown) and long
inverted repeats may cause plasmid loss.
To test the effects of neighboring sequences and structures,
we compared several additional design variants. First, the 50
leader sequence was removed from PT2 (PT4), and this
showed no improvement (P ¼ 0.49). Second, the 30 extension
extension sequence was removed from PT4 (PT5), and this
even reduced inhibition (P < 0.01) (Figure 2B). Third, the
PT structure was expressed adjacent to the antisense cassette
(PT6), and this construct was not inhibitory. Also, to ensure
that silencing is gene selective and dependent on an antisense
sequence, we included empty vector controls and PT4-bla
asRNA (complementary to the bla gene) as an unrelated con-
trol, and observed no inhibition (Figure 2B, shown in ‘-’ and
‘-*’). Therefore, a 38 base PTasRNA design is advantageous
over the standard design.
To assess whether antisense cassette size affects inhibition,
we compared the 147 base asRNA (type L) with a shorter 29
base asRNA (type S). Both versions were inhibitory
(Figure 2C), indicating that the PT design works with differ-
ent sized asRNA cassettes.
As a further comparison to reported silencing technology,
we expressed a ‘parallel complementary RNA’ designed to
express a parallel sequence of the ackA gene; the sequence
Figure 2. Silencing of plasmid-encoded ackA-lacZ by PT asRNAs driven by weak (Pbad) and strong (Ptrc) promoters. (A) Schematic of the ackA-lacZ fusion
mRNA, two types of ackA asRNAs (type L and type S) and an ackA parallel complementary RNA (type P). (B) Silencing by asRNAs with various PT and
flanking structures. b-galactosidase activities were determined in the presence of arabinose. Cells were co-transformed with the ackA-lacZ reporter and ackA
antisense plasmids. PT type (1–6, see also Figure 1) and absence (-) or presence (L) of ackA asRNA are shown at bottom. The ‘-’ with an asterisk is an unrelated
bla asRNA (191 bp) control. (C) Silencing by long and short asRNA cassettes as well as a parallel complementary RNA cassette. (D) Silencing by asRNAs
driven by the Ptrc. b-galactosidase activities are shown as in (B), except that gray and open bars indicate b-galactosidase activities in the absence and presence of
IPTG, respectively. Note that PT4-asRNA driven by the Ptrc is transcribed constitutively because the lac operator is absent. Average values are from triplicate
experiments with std values indicated.
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UGUCGAGUA-30, while the sequence of the parallel
complementary RNA is 50-AUGAGCUGUACCUUCAUGG-
AUAUUAACUA-30 (shown as type P in Figure 2A).
Tchurikov and co-workers reported that the inhibition efﬁci-
ency of parallel complementary RNAs exceeds asRNAs when
targeted to the lon mRNA (8). However, we observed no
inhibition with a parallel complementary RNA targeted to
the ackA mRNA (Figure 2C). We used the 147 base
asRNA for further experiments.
To further improve inhibition efﬁciency, the 38 base PT
design (PT4) was altered by replacing Pbad and araC with
Ptrc. The Ptrc is stronger than Pbad (27) and we expected
the Ptrc construct to express more asRNAs than Pbad. Consis-
tent with this we observed improved inhibition (Figure 2D).
This result suggests that asRNA abundance is an important
parameter. To provide IPTG-inducible control to the Ptrc con-
struct, the lac operator sequence (and also lacI
q) was inserted
(PT7) and we observed inducible ackA inhibition
(Figure 2D). Finally, to conﬁrm the need for PT in the PT7
construct, the downstream portion of the PT7 duplex was
deleted (PT7D), and this construct was less effective. While
less efﬁcient than the intact PT7 construct, ackA-PT7D
asRNA expressed from Ptrc was almost as effective as
ackA-PT4 asRNA expressed from Pbad. This may reﬂect the
fact that Pbad is weaker than Ptrc or that Pbad produces an
inhomogeneous culture, containing subpopulations of differ-
entially induced cells, due to aspects of the arabinose uptake
system (28).
To test the level of genetic penetrance at the colony
and cell level, another reporter plasmid containing an ackA-
DsRed fusion (red ﬂuorescent protein) (29) was constructed
and targeted with the ackA-PT7 asRNA. Following ackA-
PT7 asRNA expression, red ﬂuorescence on plates was
uniformly reduced in all colonies examined (Supplementary
Figure S2) and ﬂuorescence microscopy indicated that most
cells expressed almost no red ﬂuorescence (Supplementary
Figure S2). Also, upon withdrawal of the inducer, red ﬂuores-
cence was restored to control levels (Supplementary
Figure S2). These results indicate that PTasRNA silencing
is penetrant and reversible.
asRNA inhibition of the chromosomal ackA-pta operon
To test whether the effects observed with reporter constructs
are observed when targeting a chromosomal gene, the effects
of asRNAs with and without PT on the native ackA-pta
expression were investigated by directly measuring AckA
and Pta activities (Figure 3). Again, the best ackA inhibition
efﬁciency was seen when ackA-PT7 asRNA was expressed
from the Ptrc (Figure 3C); 78% of AckA activity was
eliminated relative to the activity of the cell expressing PT7
with no asRNA sequence. Because the pta gene is co-
transcribed with ackA, Pta activity was measured following
ackA-PT7 asRNA induction, and was reduced by 48%
(Figure 3D), indicating inhibition of the whole operon. Simi-
lar downstream gene inhibition occurs when lacZ is inhibited
within in the lacZYA operon (30), and this may reﬂect
expression coordination mechanisms within operons (12).
Target and antisense RNA abundance and stability
When asRNAs hybridize with target mRNAs and inhibit gene
expression, the mechanism of inhibition could be repression
of translation initiation or triggered mRNA decay (5,11).
To learn more about silencing by PTasRNAs, we probed
ackA-pta mRNA abundance. Total RNAs were puriﬁed
from cells grown in the presence or absence of inducers
and were subjected to northern analysis (Figure 4). The
asRNAs that reduced gene expression at the protein level
also reduced mRNA abundance (Figure 4B, the result with
probe A). The near parallel silencing pattern suggests that
triggered mRNA decay is the major mechanism of antisense
inhibition in this case. Residual AckA-Pta activities could be
due to long half lives for these proteins following efﬁcient
mRNA silencing.
If the PTasRNAs are stabilized and expressed in large
quantities, asRNA levels in cells should increase with PT
addition. Therefore, we probed asRNAs in all ackA-asRNA
Figure 3. Inhibition of ackA-pta expression by asRNAs. (A) Schematic maps of the ackA-pta operon mRNA and the ackA asRNA are shown. (B) An illustration
of central carbon flux. Acetyl-P is acetyl phosphate. (C) Silencing of AckA in the absence (a gray bar) and presence (open bars) of inducer. Cells were
transformed with ackA antisense plasmids as indicated. Activity values are the average of three replicates with std values indicated. (D) Pta activity values as
shown for AckA.
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The probe B result (Figure 4B) shows that the amount of ackA-
PT1 asRNA expressed from the Pbad was higher than
ackA asRNA without PT ( 2-fold) expressed from the Pbad.
Also, the amounts of ackA-PT4 asRNA expressed from the
Pbad and ackA-PT7 asRNA expressed from the Ptrc were
higher than ackA asRNA without PT ( 15- and 24-fold,
respectively). We quantiﬁed ackA mRNA and asRNA band
intensities and conﬁrmed a negative correlation between
asRNA abundance and residual mRNA levels (R
2 ¼ 0.912;
P < 0.0001, see Supplementary Figure S3). These results fur-
ther support the idea that high asRNA abundance is needed
for efﬁcient silencing.
The major bands for ackA-PT1 asRNA, ackA-PT4 asRNA
and ackA-PT7 asRNA (lower bands, shown as 30 truncated
asRNA) migrated faster than expected. Predicted RNA
lengths for ackA asRNA without PT, ackA-PT1 asRNA,
ackA-PT4 asRNA and ackA-PT7 asRNA were 454, 479,
495 and 499 bp, respectively, but the major bands for
PT-containing-asRNAs appeared to be  250 bp. Further-
more, the major bands were not detected by probe C
(Figure 4B, the lowest panel). These results indicate that
ackA PTasRNAs lack 30 end single stranded sequences,
possibility due to premature termination following transcrip-
tion of the PT sequences or rapid degradation of the
30 sequences up to the paired structure. Given the lack of
signals in these lanes when using probe C and the similarity
between PT and Rho-independent terminators, we favor
premature termination (Figure 4B, the lowest panel). Also,
similar premature termination has been reported for ribozyme
sequence ﬂanked by inverted repeats (31).
Next, we determined half-lives of ackA asRNAs by stop-
ping de novo transcription in growing cells with rifampicin.
Quantiﬁcation of northern band intensities (Figure 4C)
showed that half-lives were prolonged by the addition of
PT. Therefore, PTasRNAs are abundant and stable, and this
may explain their improved efﬁcacy. The half-life for ackA-
PT7 asRNA expressed from the Ptrc was twice that of ackA-
PT4 asRNA expressed from the Pbad, although the PT struc-
tures differ only slightly.
To test whether the PT duplex or asRNA/mRNA duplex
are cleaved by the double strand selective RNase III, the
northern analyses was repeated in RNase III minus cells
and in the same cells expressing plasmid-encoded RNase
III. Expression of RNase III did not alter PTasRNA mobility
or abundance and did not alter silencing (Supplementary
Figure S4), indicating an RNase III independent silencing
mechanism.
Effect of ackA-PTasRNAs on acetate metabolism
An ackA-pta deletion mutant produces less acetate than wild-
type cells due to limited carbon ﬂux to acetate (32). To test
whether ackA-PTasRNA induction reduces acetate produc-
tion, we measured acetate concentrations in liquid minimal
media (M9) containing a high amount of glucose. The
ackA-PT7 asRNA expressed from the Ptrc was used because
this construct showed the best efﬁciency in the earlier assays
(Figure 3C). Following ackA-PT7 asRNA induction, acetate
levels were reduced  30% (Figure 5). Note that E.coli carries
at least two pathways for producing acetate (AckA-Pta and
PoxB pathways) (33). Therefore, acetate levels are expected
to be only partially reduced with inhibition of AckA activity,
as observed here.
AckA is needed for E.coli to use acetate as a carbon source
at high acetate concentrations (acetate scavenging) (34,35).
To test whether ackA-PT7 asRNA induction prevents growth
on acetate, growth on minimal media containing either
glucose or acetate as a primary carbon source was evaluated.
When cells expressing the ackA-PT7 asRNA were grown on
acetate media, colony formation was abolished completely
(Figure 6). E.coli carries at least two pathways for scavenging
acetate (AckA-Pta and Acs pathways) (33), and the
present results are consistent with reports that AckA-Pta is
needed for acetate scavenging (34). Essentially identical
results were obtained using TOP10, wild-type K12 and
BL21(DE3) (a derivative of E.coli B strain) strains
(Figure 6), indicating that the asRNA method works well
in several E.coli strains. Therefore, with high induction,
Figure 4. Northern blot analysis of ackA mRNA and asRNAs. (A) Schematic
maps of the ackA-pta operon mRNA (left) and ackA asRNAs (right) with
three probes (Probe A–C) used for hybridization. (B) Effect of PT and control
structures on ackA mRNA and asRNA abundance. Probes A, B and C target
ackA mRNA, the ackA asRNA sequence and the downstream sequence of PT,
respectively. The rRNA bands stained with ethidium bromide (EtBr) were
used as loading controls. (C) Effect of PT and control structures on asRNA
half life. Total RNA was purified from cells harvested at the indicated time
points following rifampicin addition and analyzed using probe B. Note that
for ackA-PT4 and ackA-PT7 asRNAs the amount of total RNA loaded was
only diluted 10-fold to enable quantification of the abundant asRNAs.
Relative band intensities were plotted in a log–linear format and half-lives
were estimated from line slopes.
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phenotypes of the null mutant.
Effect of ackA-PTasRNAs on heterologous
protein expression
Reduced acetate production is advantageous in several indus-
trial applications. For example, ackA-pta negative strains
show improved heterologous protein production (32), but suf-
fer from slow growth rates. Conditional ackA-pta inhibition
should permit rapid growth but enable carbon to be redirected
from acetate at a late growth stage to enhance heterologous
protein production. To test this possibility, we introduced a
GFP plasmid (model of a heterologous protein) into cells
containing a constitutive or inducible ackA-PT asRNAs plas-
mid. The results shown in Figure 7A indicate that ﬁnal GFP
ﬂuorescence was enhanced 1.9-fold using ackA-PT7 and 2.5-
fold using ackA-PT4 asRNA. Also, spot application of IPTG
on cells grown on M9Z glucose plates showed increased
green ﬂuorescence when ackA-PT7 asRNA was co-expressed
with GFP (Figure 7B).
Effect of fabI asRNAs on cell growth and
triclosan sensitivity
To ask whether PTasRNAs are suitable for studies of
genes essential for growth, we targeted the fabI gene
encoding enoyl-ACP reductase, which is essential for fatty
acid biosynthesis and vegetative growth (36) (Figure 8A).
The results (Figure 8B) indicate that growth inhibition was
observed only when cells harboring the fabI-PT7 asRNA
plasmid were plated onto 1 mM IPTG-containing media.
We also expressed fabI asRNAs lacking PT from Pbad and
no inhibition was observed (data not shown). Again, the
inhibition efﬁciency of PT7-asRNA expressed from Ptrc
was higher than when using the standard design, indicating
that this PT design provides a reliable strategy to inhibit tar-
get gene expression.
If the growth inhibitory fabI asRNAs are fabI selective,
partial inhibition should sensitize cells to the FabI inhibitor,
triclosan (37,38), but not to inhibitors that target other cellu-
lar processes. To evaluate inhibitor sensitivity, we used a
zone of inhibition assay (11) and fabI expression was
partially silenced using fabI-PT7 asRNA induced with
0.04 mM of IPTG (Figure 8C). On plates containing cells
expressing fabI-PT7 asRNA, the zone of clearing for triclosan
was enlarged relative to cells expressing control PT7 RNA
without an antisense insert, indicating sensitization. Zone
sizes were not altered for the unrelated inhibitors, trimetho-
prim (inhibitor of dihydrofolate reductase type I) and
rifampicin (inhibitor for RNA polymerase b subunit)
(Figure 8C). Therefore, cells expressing fabI-PT7 asRNA
are selectively sensitized to triclosan.
DISCUSSION
PT asRNAs provide improved gene silencing tools for E.coli.
Bacterial RNAs are typically short lived, and there is evi-
dence that half-life is an important factor in asRNA efﬁcacy
(2,6) and that a molar excess of asRNAs (and ribozymes) is
required for efﬁcient inhibition (4). An excess relative abun-
dance should enable asRNAs to efﬁciently out-compete ribo-
somes at target RNAs. Therefore, the improved efﬁcacy of
PTasRNAs appears to be due to improved stability, which
raises asRNA abundance. Also, it is possible that termini
pairing aids target recognition by constraining the folded
RNA. Finally, following mRNA recognition, PTasRNAs
may trigger intrinsic decay mechanisms (39), which are
apparently independent of RNase III, but may involve
RNase E, or other RNases.
PTasRNAs are effective, yet we suspect that further
improvements are possible. For example, target site position
and length issues are not well addressed here, nor in the
literature, although it is clear that target selection is an
important factor. Most natural asRNAs target the translation
Figure 5. Effect of ackA asRNA on acetate production. (A) Culture turbidity
(upper panels, absorbance at 550 nm) and extra-cellular acetate concentra-
tions (lower panels) for each transformant are shown. Cells were grown in M9
plus glucose media with or without IPTG at 37 C. Values are the average of
triplicate experiments with std values indicated. (B) AckA activities in
cultures harvested during the logarithmic phase of growth in the absence
(gray bars) and presence (open bars) of IPTG. Note that M9 plus glucose
media was used in this experiment.
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reasonable choice for most genes, but other susceptible
regions exist (11). Successful asRNA cassettes as short as
12mer have been reported (6); however, in the absence of
knowledge about target accessibility, we favor larger anti-
sense cassettes, which are more likely to contain structures
that efﬁciently seed hybridization. Indeed, we found that
the inhibition efﬁciency of a 147 base cassette exceeded
that of a 29 base cassette (Figure 2C). Further comparisons
are needed on this issue, and target accessibility prediction
tools (12,42) may be helpful. Also, recA
  strains showed
more stable inhibition (data not shown) and we observed
improved results in solid media relative to liquid media,
possibly due to plasmid stability problems in liquid culture.
Plasmid stability is a common problem, and plasmids con-
taining growth inhibitory sequences and long inverted repeats
may be unstable (43). Therefore, PT length should be the
minimum that provides asRNA stability without compromis-
ing plasmid stability. Therefore, while the PT design proved
effective against all genes and in all strains tested, it is clear
that plasmid stability requires attention.
The effects of PTasRNAs may reﬂect the action of certain
natural RNAs. For example, natural asRNAs are also stabi-
lized by paired sequences, and in the case of the FinP natural
asRNA, stability and target interaction is promoted by the
RNA chaperone FinO recognition of paired sequences (44).
Also, the R1 plasmid encoded Hok toxin mRNA is processed
into a stable isoform with perfectly matched PT (45). There-
fore, PTasRNA effects may reﬂect endogenous mechanisms
for stabilizing RNA and promoting interactions.
 
 
 
Figure 6. Effect of ackA PTasRNA on cell growth on glucose or acetate media. TOP10 (upper two panels), WT K12 (middle two panels) or BL21(DE3) cells
(lower two panels) carrying the indicated plasmids were streaked from colonies (upper panels). Cells were spotted from liquid pre-culture serially diluted 1:10
(lower panels), where the spots at right are for 2.5 ml cultures diluted 1:10
1 from the pre-culture and the left-most spots are for 2.5 ml aliquots diluted 1:10
5 from
pre-cultures. Cells were grown on M9 solid media with either 2% glucose or 2 mg/ml sodium acetate as a carbon source at 37 C. In the absence of IPTG, the
TOP10 cells harboring ackA-PT7 asRNA-expressing plasmid grew slowly compared to control cells, indicating that ackA-PT7 asRNA expression was leaky.
Figure 7. Expression of ackA-PTasRNAs enhances GFP expression. (A) GFP
expression in M9Z glucose broth following ackA-asRNAs co-expression.
Expressed RNAs include control PT7 with no asRNA (squares), ackA-PT7
asRNA (diamonds) and ackA-PT4 asRNA (crosses). As an additional control,
cells with only the GFP expression plasmid (circles) were included. The left
panel shows growth curves and the right panel shows relative GFP
fluorescence intensity. Averaged values from triplicate experiments are
shown with sem. Note that the PT4-asRNA is expressed constitutively. (B)
GFP expression on solid media. The co-transformants were pre-grown
overnight in liquid media, 5 ml aliquots were diluted with 200 ml of M9Z
glucose media and plated evenly throughout the M9Z glucose solid media,
and 5 ml of 1M IPTG was spotted onto the center of the plates. Plates were
incubated for 24 h. Points of IPTG application are indicted by arrows.
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and apply asRNA gene silencing in many applications.
Forward and reverse RNA level genetics can be considered
(46), and there are potential applications in pharmaceutical
discovery and metabolic engineering. For example, improved
conditional redirection of metabolic ﬂux could enhance
metabolic engineering, and here we show that ackA asRNA
induction in mid-growth phase increases heterologous gene
expression. Also, silencing of essential genes can aid
discovery of much needed new antimicrobials (11,40), as
demonstrated recently with the discovery of platensimycin
(47), and here we show improved drug target silencing
and inhibitor sensitization. Finally, for applications in other
bacterial species, interspecies differences in asRNA and
RNase activities (48,49) should be considered, but we suspect
that the PT design and information about the stability and
abundance of asRNAs will enable improved silencing.
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